Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | CVP,PRES - CODMAN SPC SURGICAL | May 11, 2020 | May 13, 2020 |
| Neuronetics, Inc.STIM · Entity 6248 | President and CEO | March 23, 2026 | March 23, 2026 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | March 11, 2025 | March 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 11, 2020 · Filed May 13, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,473 |
Ending reported balance
After 2020-05-11 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2020-05-11 · Exercise / conversion · Acquired 2,420 · Balance 44,893 Row 2 · 2020-05-11 · Sale · Disposed 2,420 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Row 3 · 2020-05-11 · Exercise / conversion · Acquired 4,978 · Balance 47,451 Row 4 · 2020-05-11 · Sale · Disposed 4,978 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Row 5 · 2020-05-11 · Exercise / conversion · Acquired 10,446 · Balance 52,919 Row 6 · 2020-05-11 · Sale · Disposed 10,446 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. Row 7 · 2020-05-11 · Exercise / conversion · Acquired 5,486 · Balance 47,959 Row 8 · 2020-05-11 · Sale · Disposed 5,486 · Balance 42,473 F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.87 · Expires 2023-03-23 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-05-11 · Exercise / conversion · Disposed 2,420 · Balance 0 F2: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015. F3: This stock option was previously reported as covering 1,047 shares of common stock at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015. F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.59 · Expires 2024-03-14 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-05-11 · Exercise / conversion · Disposed 5,486 · Balance 0 F5: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016. F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.43 · Expires 2024-12-01 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-05-11 · Exercise / conversion · Disposed 10,446 · Balance 0 F6: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016. F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.68 · Expires 2025-03-13 | Direct | 1,660 |
Reported balance
After 2020-05-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-05-11 · Exercise / conversion · Disposed 4,978 · Balance 1,660 F7: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017. |
| Common StockSEC Table I · non-derivative | IndirectBy Children | 200 |
Reported balance
Holding disclosure · report date 2020-05-11 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.45 to $52.871.
F2: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015.
F3: This stock option was previously reported as covering 1,047 shares of common stock at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
F4: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
F5: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/14/2016.
F6: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016.
F7: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/13/2017.
Neuronetics, Inc.
Report date March 23, 2026 · Filed March 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,500,000 |
Reported balance
After 2026-03-23 transaction · row 1
1 source rowRow 1 · 2026-03-23 · Grant · Acquired 1,500,000 · Balance 1,500,000 F1: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
TACTILE SYSTEMS TECHNOLOGY INC
Report date March 11, 2025 · Filed March 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 146,442 |
Reported balance
After 2025-03-11 transaction · row 1
1 source rowRow 1 · 2025-03-11 · Gift · Disposed 68,162 · Balance 146,442 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 68,162 |
Reported balance
After 2025-03-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-03-11 · Gift · Acquired 68,162 · Balance 68,162 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2020 Filed Mar 17, 2020 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019568 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Indirect · By Children Disclosed balance after: 200 F1 · kind: This transaction involved a gift of securities by the reporting person to his two adult children, who do not share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his two children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children shares for purposes of Section 16 or any other purpose. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010221 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,878 F3 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010221 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,175 F2 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010221 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,582 F1 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 5,000 | $60.00 | $300,000.00 |
DisclosureSEC source: 0001209191-19-043327 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,392 F1 · kind: The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 110 | $56.14 | $6,175.40 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 7 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,392 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 411 | $56.14 | $23,073.54 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,502 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,526 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · derivative · entry 8 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,526 Underlying: Common Stock · 9,526 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 5 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,913 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 181 | $55.91 | $10,119.71 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,784 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 156 | $55.91 | $8,721.96 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,965 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 404 | $55.91 | $22,587.64 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,121 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 583 | $55.91 | $32,595.53 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,525 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,108 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,638 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,513 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 10,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062474 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,016 Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,000 | $66.97 | $66,970.00 |
DisclosureSEC source: 0001209191-18-038586 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,009 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:08 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,000 | $62.04 | $62,044.50 |
DisclosureSEC source: 0001209191-18-027063 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,009 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $62.01 to $62.15. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:43 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 268 | $54.15 | $14,512.20 |
DisclosureSEC source: 0001209191-18-021809 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,009 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:43 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 268 | $54.15 | $14,512.20 |
DisclosureSEC source: 0001209191-18-021809 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,277 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 399 | $56.14 | $22,399.86 |
DisclosureSEC source: 0001209191-18-019850 · doc4.xml · nonDerivative · entry 5 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,545 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 107 | $56.14 | $6,006.98 |
DisclosureSEC source: 0001209191-18-019850 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,944 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 7,714 | $0.00 Strike: $56.23 | $0.00 |
DisclosureSEC source: 0001209191-18-019850 · doc4.xml · derivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,714 Underlying: Common Stock · 7,714 shares Expires 2026-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2018. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 583 | $56.23 | $32,782.09 |
DisclosureSEC source: 0001209191-18-019850 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,051 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 156 | $56.23 | $8,771.88 |
DisclosureSEC source: 0001209191-18-019850 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,634 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019850 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,790 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:49 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011392 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,798 F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:49 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011392 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,674 F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:49 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 974 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011392 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,222 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 476 | $42.74 | $20,344.24 |
DisclosureSEC source: 0001209191-17-023013 · doc4.xml · nonDerivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,248 Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 476 | $42.74 | $20,344.24 |
DisclosureSEC source: 0001209191-17-023013 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,724 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 288 | $42.35 | $12,196.80 |
DisclosureSEC source: 0001209191-17-023013 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,200 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 288 | $42.35 | $12,196.80 |
DisclosureSEC source: 0001209191-17-023013 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,488 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 118 | $43.03 | $5,077.54 |
DisclosureSEC source: 0001209191-17-020796 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,776 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 441 | $43.03 | $18,976.23 |
DisclosureSEC source: 0001209191-17-020796 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,894 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 6,638 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-17-020796 · doc4.xml · derivative · entry 4 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,638 Underlying: Common Stock · 6,638 shares Expires 2025-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020796 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,335 Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:37 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012155 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,617 F4 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2017 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:37 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012155 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,168 F3 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 33% of the shares will vest on March 23, 2017, the second anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:37 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012155 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 F1 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 24, 2014 Performance Stock Award. Accordingly, 34% of the shares will vest on March 24, 2017, the third anniversary of the grant date. F2 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date and one additional unit of unvested performance based restricted stock ("PSU") for each PSU owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 21:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,223 | $0.00 Strike: $76.85 | $0.00 |
DisclosureSEC source: 0001209191-16-153329 · doc4.xml · derivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES-SPC SURGICAL SOLUTION 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,223 Underlying: Common Stock · 5,223 shares Expires 2024-12-01 F1 · derivative.exercise_date: 100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.